Skip to main content

GOLDMAN SACHS GROUP INC

Position in MREO — Mereo BioPharma Group plc

CIK 886982 NEW YORK, NY

Position in MREO

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$27,087
+$15,401 QoQ
Shares Held
85,180
+203.9% QoQ
Ownership
0.053%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#23
of 58 holders
Holding Since
Dec 2021
18 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in MREO Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GOLDMAN SACHS GROUP INC holds $13,040,380,016 across 360 Biotechnology names. MREO ranks #342 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in MREO

Export CSV
18 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $27,087 85,180
2025-12-31 $11,686 28,026
2025-09-30 $4,869,889 2,364,024
2025-06-30 $8,374,084 3,090,068
2025-03-31 $4,783,320 2,125,920
2024-12-31 $7,419,482 2,119,852
2024-09-30 $8,254,445 2,008,381
2024-06-30 $9,027,046 2,507,513
2024-03-31 $7,404,586 2,243,814
2023-12-31 $4,674,682 2,023,672
2023-09-30 $2,610,536 2,023,672
2023-06-30 $2,616,775 1,982,406
2023-03-31 $1,599,788 2,262,785
2022-12-31 $1,721,074 2,294,766
2022-09-30 $610,557 709,126
2022-06-30 $803,549 717,455
2022-03-31 $801,007 715,185
2021-12-31 $1,139,780 712,363